White coat effect in patients with hypertension

被引:0
|
作者
Andreeva, G. F. [1 ]
Gorbunov, V. M. [1 ]
Antipushina, D. N. [1 ]
Platonova, E., V [1 ]
机构
[1] Natl Med Res Ctr Therapy & Prevent Med, Moscow, Russia
关键词
hypertension; white coat effect; 24-hour blood pressure monitoring; AMBULATORY BLOOD-PRESSURE; ANTIHYPERTENSIVE TREATMENT; ARTERIAL-HYPERTENSION; PULSE PRESSURE; HOME; DIFFERENCE; OFFICE; DETERMINANTS; REACTIVITY; PREVALENCE;
D O I
10.20996/1819-6446-2023-2926
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The article is devoted to various aspects of white coat effect (WCE) in patients with hypertension (HTN). WCE is due to the patient's anxious response to office blood pressure (BP) measurement and is characterized by a BP increase. In patients with HTN, WCE is detected with a high frequency. Pronounced WCE in hypertensive patients is associated with worsening the HTN course and the prognosis of all-cause and cardiovascular mortality. In addition, BP increase in these patients during a doctor's visit may lead to additional prescription of antihypertensive drugs, increasing costs and side effects. To identify WCE, a large number of methods are used, which can be divided into following groups: I - data from clinical and daytime ambulatory blood pressure measurement, II - clinical and home BP assessment, III - only ambulatory BP measurement, IV - clinical and laboratory BP data, and V - only clinical BP measurement. There are following WCE in patients with HTN: female sex, age, never smoking, as well as anxiety, introversion, etc. WCE is due to the patient's anxiety state during office BP measurement and a conditioned reflex BP increase associated both with the physician presence and medical background. Severe WCE in some groups of patients with HTN may be associated with a worse prognosis compared with other hypertensive patients as follows: in individuals with a significant difference between clinical and ambulatory blood pressure levels or between the first and third BP office data, with a combination of resistant HTN and WCE, with WCE increasing from visit to visit, etc.
引用
收藏
页码:508 / 519
页数:12
相关论文
共 50 条
  • [31] THE SUBCLINICAL INFLAMMATION IN PEDIATRIC PATIENTS WITH PRIMARY HYPERTENSION AND WHITE COAT HYPERTENSION
    Dziedzic-jankowska, Katarzyna
    Bujanowicz, Adam
    Szyszka, Michal
    Stelmaszczyk-emmel, Anna
    Skrzypczyk, Piotr
    [J]. JOURNAL OF HYPERTENSION, 2024, 42
  • [32] RENAL SODIUM HANDLING IN PATIENTS WITH UNTREATED HYPERTENSION AND WHITE COAT HYPERTENSION
    BURNIER, M
    BIOLLAZ, J
    MAGNIN, JL
    BIDLINGMEYER, M
    BRUNNER, HR
    [J]. HYPERTENSION, 1994, 23 (04) : 496 - 502
  • [33] P.074 Effect of Smoking on Arterial Stiffness in Patients with White Coat Hypertension
    S.-M. Kyvelou
    C. Vlachopoulos
    G. Vyssoulis
    P. Pietri
    P. Spanos
    K. Baou
    P. Xaplanteris
    C. Stefanadis
    [J]. Artery Research, 2007, 1 (2) : 69 - 70
  • [34] White coat effect at primary care. An analysis in patients with recently diagnosed hypertension
    Mayoral, E
    Lapetra, J
    Santos, JM
    Lopez, A
    Ruiz, J
    Cayuela, A
    [J]. MEDICINA CLINICA, 1997, 108 (13): : 485 - 489
  • [35] Age-related arterial stiffness in patients with essential hypertension and white coat effect
    Vyssoulis, G.
    Karpanou, E.
    Keramida, K.
    Kyvelou, S.-M.
    Pietri, P.
    Gymnopoulou, E.
    Antonakoudis, G.
    Cokkinos, D.
    Stefanadis, C.
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 : S321 - S321
  • [36] White-coat hypertension
    Martin, Catherine A.
    McGrath, Barry P.
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2014, 41 (01) : 22 - 29
  • [37] Lipoprotein (A) in white coat hypertension
    Coban, E
    Yavuz, A
    Ozdogan, M
    Akcit, F
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V59 - V60
  • [38] Decoding white coat hypertension
    Dennis A Bloomfield
    Alex Park
    [J]. World Journal of Clinical Cases, 2017, (03) : 82 - 92
  • [39] White coat hypertension in children
    Sorof, JM
    [J]. BLOOD PRESSURE MONITORING, 2000, 5 (04) : 197 - 202
  • [40] Treatment of white coat hypertension
    Chrysant S.G.
    [J]. Current Hypertension Reports, 2000, 2 (4) : 412 - 417